Panel Discussion: The Evolving Clinical, Regulatory & Commercial Paradigm in Dermatology

Time: 10:45 am
day: Day Two


• Exploring how to overcome key challenges in dermatology clinical development
• Assessing the need for cooperation between regulators, payers and drug developers in the definition of appropriate endpoints in the development of therapies targeting rare diseases
• Supporting value-based evidence to external stakeholders – establishing the value of new therapies and effectively demonstrating improved outcomes
• Discussing the different payer requirements between Europe and US
• Navigating the challenges of a crowded development space